Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Emtricitabine/Tenofovir disoproxil Mylan“
Suchtreffer
Begriffe & Kennungen
Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 16 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 17 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 18 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 19 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 20 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 21 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 22 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 23 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 24 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 25 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 26 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 27 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 28 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 29 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 30 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 31 Studies conducted with other medicinal products
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · As Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan contains efavirenz, emtricitabine and tenofovir disoprox
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · As a fixed combination, efavirenz/emtricitabine/tenofovir disoproxil should not be administered concomitantly
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · Atazanavir/ritonavir/Emtricitabine Interaction not studied.
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · Atazanavir/ritonavir: Insufficient data are available to make a dosing recommendation for atazanavir/ritonavir
Eintrag öffnen